Geron Corporation

LSE (USD): Geron Corporation (0IV3)

Last Price

3.75

Today's Change

-0.079 (2.06%)

Day's Change

3.75 - 3.98

Trading Volume

24,385

Overview

Market Cap

2 Billion

Shares Outstanding

593 Million

Avg Volume

12,482

Avg Price (50 Days)

2.07

Avg Price (200 Days)

2.45

PE Ratio

-10.45

EPS

-0.36

Earnings Announcement

01-Aug-2024

Previous Close

3.83

Open

3.98

Day's Range

3.752 - 3.98

Year Range

1.731 - 3.98

Trading Volume

24,385

Price Change Highlight

1 Day Change

-2.06%

5 Day Change

-4.29%

1 Month Change

-0.48%

3 Month Change

82.14%

6 Month Change

90.46%

Ytd Change

71.32%

1 Year Change

25.48%

3 Year Change

160.56%

5 Year Change

134.50%

10 Year Change

85.74%

Max Change

85.74%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Pharmaceuticals, Biotechnology & Life Sciences

Description:

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment